UK generic use soared in 2013

Share this article:

Generics made up almost 75% of prescriptions in the United Kingdom last year. Medical News Today grabbed the statistic from the Health and Social Care information Centre and said competition among Lipitor generics “delivered the greatest decrease in cost of any medicine over the last year.”

A key term to note for those looking for US parallels is generic competition: The New York Times pointed out earlier this month that generics are a bargain as long as four to five manufacturers are fighting over market share, otherwise generic drug prices can skyrocket, as they have with generic digoxin in the US.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.